Collegium Pharmaceutical

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$209,361
$188,000
$177,757
$181,949
Gross Profit
129,171
108,384
97,324
98,288
EBITDA
121,709
94,096
80,476
96,435
EBIT
65,203
37,488
23,912
39,923
Net Income
31,507
11,983
2,417
12,536
Net Change In Cash
209,361
188,000
177,757
181,949
Free Cash Flow
78,250
72,374
54,600
84,074
Cash
169,946
117,348
96,192
70,565
Basic Shares
39,439
39,075
32,840
40,109

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$631,449
$566,767
$463,933
$276,868
Gross Profit
377,344
326,169
209,488
150,617
EBITDA
341,702
308,328
173,305
86,557
EBIT
172,542
159,072
34,366
17,640
Net Income
69,190
48,155
-25,002
71,517
Net Change In Cash
631,449
566,767
463,933
276,868
Cost of Revenue
-12,738
12,310
Free Cash Flow
203,328
274,288
122,608
101,613
Cash
70,565
238,947
173,688
186,426
Basic Shares
40,424
41,788
33,829
41,045

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$2.25
2025-06-30
$0.34
2025-03-31
$1.49